pulmonary eosinophilia
pulmonary eosinophilia
Explore linked clinical trials. Standard reference: MONDO:000480226 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07323654 | |
| A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 3 | 2026-09-29 | NCT05692180 | |
| Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 4 | 2026-09-25 | NCT03953300 | |
| Real-World Effectiveness of Depemokimab in Allergic Bronchopulmonary Aspergillosis With Severe Eosinophilic Asthma | Bacterial Infections and Mycoses, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, allergic bronchopulmonary aspergillosis, aspergillosis, fungal infectious disease, fungal lung infectious disease, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, pulmonary aspergilloma, pulmonary eosinophilia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not applicable | 2026-09-24 | NCT07828327 | |
| A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Not stated | 2026-09-18 | NCT07214753 | |
| Fasenra: An Asthma Study | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Enrolling by invitation | Phase 4 | 2026-09-15 | NCT07654842 | |
| A Non-interventional, Prospective Study With Benralizumab | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Recruiting | Not stated | 2026-08-28 | NCT06422078 | |
| A Study of Depemokimab in Participants of 6 to 11 Years of Age | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 3 | 2026-08-26 | NCT07671001 | |
| REverse LuNg Airway and Vascular RemOdeling in Asthma ReMission (ReNORM) | Airway Remodeling, Eosinophilia, Hemic and Lymphatic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Not yet recruiting | Not applicable | 2026-07-31 | NCT07174713 | |
| Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 3 | 2026-05-13 | NCT06750289 | |
| Mepolizumab and Physical Activity in Severe Asthma | Dyspnea, Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Hypersensitivity, Signs and Symptoms, Signs and Symptoms, Respiratory, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Not stated | 2026-04-24 | NCT05404763 | |
| Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, polyp, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Not stated | 2026-04-17 | NCT06069310 | |
| SIM0718 Treatment of Asthma Clinical Study | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 3 | 2026-04-02 | NCT06488755 | |
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA | Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, asthma, autoimmune disease, bronchial disorder, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Enrolling by invitation | Phase 4 | 2026-01-15 | NCT07343661 | |
| A Multi-dose Study on the Safety and Efficacy of Self-administered Intranasal AD17002 Treatment for Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Not yet recruiting | Phase 2 | 2025-11-26 | NCT07250594 | |
| A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 3 | 2025-09-05 | NCT05748600 | |
| Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Not applicable | 2025-08-11 | NCT03733535 | |
| A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Phase 4 | 2025-07-01 | NCT05942222 | |
| Eosinophil Subpopulations in Eosinophilic-associated Diseases | Eosinophilia, Granuloma, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, eosinophilic granulomatosis with polyangiitis, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, necrotizing vasculitis, pulmonary eosinophilia, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Not yet recruiting | Not stated | 2025-04-04 | NCT06911775 | |
| The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Active, not recruiting | Not stated | 2025-02-19 | NCT05144087 | |
| Homeostatic Roles of Eosinophils in Asthma | Eosinophilia, Hemic and Lymphatic Diseases, hematologic disorder, hypereosinophilic syndrome, leukocyte disorder, lung disorder, pulmonary eosinophilia, respiratory system disorder | Not yet recruiting | Not applicable | 2024-11-06 | NCT06676397 | |
| Predictive Signature of Benralizumab Response | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Recruiting | Phase 4 | 2024-04-26 | NCT04565483 | |
| Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Not yet recruiting | Phase 1 | 2024-02-21 | NCT06270576 | |
| Severe Eosinophilic Asthma Phenotypes During Childhood Have Various Origins | Eosinophilia, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, hematologic disorder, hypereosinophilic syndrome, immune system disorder, leukocyte disorder, lung disorder, obstructive lung disease, pulmonary eosinophilia, respiratory system disorder | Not yet recruiting | Not stated | 2023-03-09 | NCT05762627 | |
| European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eosinophilia, Fibrosis, Hemic and Lymphatic Diseases, Infant, Newborn, Diseases, Infant, Premature, Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Respiratory Distress Syndrome, Newborn, adult acute respiratory distress syndrome, hematologic disorder, hypereosinophilic syndrome, interstitial lung disease, leukocyte disorder, lung disorder, pulmonary alveolar proteinosis, pulmonary eosinophilia, pulmonary fibrosis, respiratory system disorder | Recruiting | Not stated | 2022-09-21 | NCT02852928 |